↓ Skip to main content

Elosulfase alfa in the treatment of mucopolysaccharidosis type IVA: insights from the first managed access agreement

Overview of attention for article published in Orphanet Journal of Rare Diseases, September 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
35 Mendeley